Jobs / United States / Kymera Therapeutics INC

Kymera Therapeutics INC

Director or Senior Director, Business Development

Watertown, MA Posted 16 days ago

Apply on company site ↗ Source: Company careers site Tailor my CV

Free account: one tailored CV and cover letter included. You always apply on the employer’s own page.

Sponsorship verdict

Sponsorship possible

One solid signal, not two. Worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 4 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
  • What Kymera Therapeutics INC paid sponsored hires in similar roles1 certified filing for “Director, Late Stage Formulations Development” (Natural Sciences Managers) in MA: $230k–$230k, median $230k.
  • Confirmed live todayWhen a source last listed this job as open.
Details and sources
Employer is on a government sponsor record
The US Department of Labor certified 4 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
No salary bar for this route
H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
What Kymera Therapeutics INC paid sponsored hires in similar roles
1 certified filing for “Director, Late Stage Formulations Development” (Natural Sciences Managers) in MA: $230k–$230k, median $230k. Most were filed at wage level II (100%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.

About the role

Who we are: Kymera is a clinical-stage biotechnology company pioneering the field of targeted protein degradation (TPD) to develop medicines that address critical health problems and have the potential to dramatically improve patients’ lives. Kymera is deploying TPD to address disease targets and pathways inaccessible with conventional therapeutics. Having advanced the first degrader into the clinic for immunological diseases, Kymera is focused on building an industry-leading pipeline of oral small molecule degraders to provide a new generation of convenient, highly effective therapies for patients with these conditions. Founded in 2016, Kymera has been recognized as one of Boston’s top workplaces for the past several years. For more information about our science, pipeline and people, please visit  www.kymeratx.com or follow us on  X (formerly Twitter)  or  LinkedIn . How we work: • PIONEER : We are courageous, resilient and rigorous in our mission to improve patients’ lives through our revolutionary degrader medicines. • COLLABORATE : We value trust + transparency from everyone. Our goals are shared, our decisions data-driven and our camaraderie genuine. • BELONG : We recognize our differences, inviting curiosity and inclusivity, so that our people are valued, seen, and heard. How you’ll make an impact: • Drive Kymera's business development strategy, positioning our targeted protein degradation platform and pipeline at the center of strategic partnerships. • Identify, evaluate, and close strategic transactions with leading biopharma companies— spanning both buy- and sell-side opportunities. • Own transactions end to end, from initial opportunity through signature agreement, working closely with R&D, legal, finance, and outside counsel. • Lead and coordinate cross-functional diligence teams. • Prepare high-quality partnering materials, including presentations, term sheets, valuation models to support transaction processes. • Lead search and evaluation processes for prioritized external opportunities. • Develop financial analyses, including forecasts, comparables, and NPV valuations, to inform critical decisions. • Lead negotiation and execution of collaboration agreements (licensing and collaboration agreements, SRAs, MTAs, and CDAs) in close partnership with internal and external council. • Represent Kymera in the industry, building relationships with BD counterparts at current and potential partner companies • Represent Kymera at partnering conferences and industry events (eg. JPM, BIO) to build and maintain relationships with potential partners and support S&E activity. Skills and experience you’ll bring: • An advanced degree — PhD, MD, or MBA — that reflects both scientific fluency and business acumen. • 8+ years of experience in business development, corporate development, or strategy consulting in biopharma. • Experience across the full deal lifecycle: sourcing, diligence, negotiation, and structuring. • Demonstrated success working with cross-functional teams and managing multiple concurrent projects • Strong strategic judgment, the ability to work independently and represent Kymera externally • NPV modeling, forecasting, and comparables analysis with the ability to communicate results clearly. • A track record of evaluating opportunities from both a scientific and commercial perspective. • Working knowledge of biopharma R&D (experience with small molecules is a plus), clinical development, and regulatory pathways • Excellent negotiation, written, and presentation skills. Equal Employment Opportunity Kymera Therapeutics is proud to be an equal opportunity employer, seeking to create a welcoming and diverse environment. All applicants will receive consideration for employment without regard to rac

Apply on company site ↗